毕得医药：舟山欣曦及其一致行动人拟减持不超2.86%股份

Group 1 - The core point of the article is that Bid Pharma (688073) announced a plan for its shareholders to reduce their stake in the company by up to 2.86% of the total share capital within three months through various trading methods [1] Group 2 - The shareholders involved in the reduction are Zhoushan Xinxie Enterprise Management Partnership and its concerted parties, Ningbo Landan Enterprise Management Partnership and Wu Bo [1] - The total number of shares to be reduced is up to 2.6035 million shares [1]